The Zenome project is a decentralized blockchain-driven database of genomic information. This platform supports the possibility to manage your genomic data while maintaining privacy and ability to make a profit from selling access to different parts of the genome. It will establish equal conditions for drug development and for the progress of scientic and medical technologies.Health Platform
It appears that the exchange of genetic information is of crucial importance. The prospective genetic market must ensure protection from possible misuse and genetic discrimination in particular. It is particularly important to maintain transparency and equal access to this market.
Zenome aims at creating the personal genomics infrastructure, that would enable participants to:
The principal customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.
Inside Zenome Platform different types of information are inextricably intertwined. The nature of each type determines the way to store information of that kind.
Treating data of different kind differently provides privacy as well as scalability of the system.
Since all data transactions, including buying and selling data, are governed by smart-contracts, interactions can only include balances stored on blockchains.
Using any of pre-existing tokens for this purpose would result in unreasonable dependence on the valuation of external token. Thus, a separate utility token should be issued to power economic interactions on the platform.
Development of web-interface capable of uploading genetic data to the network and providing personalized genetic report.
The first service provider on the Zenome platform.
The establishment of a network for distributed storing of genetic information.
Development of a client application capable of uploading genetic data from user's PC.
Using smart-contacts to enforce operations with genetic data: buying, selling, transferring.
The establishment of Zenome Fund to support projects based on a platform.
The Main Committee of Zenome Fund would be established.
The establishment of a broad network of partnerships with genetic labs.
Collecting genetic material and adding these DNA samples to the network.
Achieve the size of 2 000 000 active users.
The start of the active genetic data exchange between the users.
Reach a partnership agreement with Big Pharma.
Start developing personalized drugs based on the genetic data collected.
Reach a partnership agreement with leading FMCG-companies.
Start developing personalized nutrition based on the genetic data collected.
|Price in ICO||1 ZNA = 0.6 USD|
|Tokens for Sale||1700000|
|Distributed in ICO||25%|
|Hard cap||1,708,096 USD|